Target intelligence / Profile preview

Hepatitis C virus 5' untranslated region (HCV 5'UTR) (HCV 5'UTR)

Target
HCV 5'UTR
Molecular classification
Other, Viral RNA, Internal Ribosome Entry Site (IRES)
01

Overview

The Hepatitis C virus 5' untranslated region (HCV 5'UTR) is a highly conserved, non-coding segment of the HCV RNA genome approximately 341 nucleotides long (Lukavsky, 2009). It plays a critical role in the viral life cycle by harboring the Internal Ribosome Entry Site (IRES), which facilitates cap-independent translation of the viral polyprotein by directly recruiting the host's 40S ribosomal subunit (Niepmann, 2013). Additionally, the 5'UTR contains specific binding sites for the liver-specific microRNA-122 (miR-122), which is essential for protecting the viral RNA from degradation and promoting its replication (Jopling et al., 2005). Because of its high conservation across genotypes and its essentiality for viral protein synthesis and stability, the 5'UTR is a prime therapeutic target. Pharmacological strategies include antisense oligonucleotides like Miravirsen that sequester miR-122, effectively starving the virus of a necessary host factor (Janssen et al., 2013). Other approaches involve ribozymes or small molecules designed to disrupt the complex secondary and tertiary structures of the IRES to halt viral protein production.

Other names
HCV 5' non-coding regionHCV 5' NCRHepatitis C virus internal ribosome entry siteHCV IRES
02

Mechanism of action

Inhibition of IRES-mediated translation initiation; Sequestration of host microRNA-122 to prevent viral RNA stabilization and replication; Cleavage of viral RNA via ribozymes or RNase H-mediated antisense activity.

03

Biological functions

OtherTranslation initiationViral RNA replicationRNA stabilizationRibosome recruitment
04

Disease associations

Infection
05

Safety considerations

Off-target hybridizationHepatocyte-specific delivery challengesViral resistance mutationsAlteration of host lipid metabolism
06

Interacting drugs

Miravirsen

3 more in the full profile.

07

Biomarkers

HCV RNA viral loadmiR-122 expression levelsHCV genotype

Beyond the preview

Go deeper on Hepatitis C virus 5' untranslated region (HCV 5'UTR) (HCV 5'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis C virus 5' untranslated region (HCV 5'UTR) (HCV 5'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call